Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06631365 · ClinicalTrials.gov registry record · Phase 2

PrEPsmart 2-1-1 Pilot

A Phase 2 study of HIV-1-infection, sponsored by Public Health Foundation Enterprises.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT06631365 is a Phase 2 study of HIV-1-infection that is actively recruiting participants, run by Public Health Foundation Enterprises. The registered enrollment target is 60 participants, below the 351-participant average among 71 other HIV-1-infection trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06631365, a Phase 2 study of HIV-1-infection, is actively recruiting participants, sponsored by Public Health Foundation Enterprises.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual minority males (SMM) taking on-demand PrEP over a 6-month period. Upon project completion, the investigators will have developed a highly innovative tool to support men who have sex with men (MSM) using on-demand PrEP ready for testing in a larger efficacy trial

Conditions Studied

HIV-1-infection

Interventions

  • DEVICE PrEPsmart mobile app
  • DRUG Truvada

Study Locations (1)

California

  • Bridge HIV, San Francisco Department of Public Health - San Francisco

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-10-02
Est. Completion 2025-04-01
Phase Phase 2

Sponsor

Public Health Foundation Enterprises

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06631365

The ClinicalTrials.gov registry entry for NCT06631365 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 71 other HIV-1-infection trials with a reported enrollment target (83% lower). The listed sponsor is Public Health Foundation Enterprises, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV-1-infection appearing as the primary indexed condition, and to 2 interventions - of which PrEPsmart mobile app is the first listed.

NCT06631365 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06631365 about?

NCT06631365 is a clinical study titled "PrEPsmart 2-1-1 Pilot". This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual minority males (SMM) taking on-demand PrEP over a 6-month period. Upon project completion, the investigators will have developed a highly inno...

What is the current status of trial NCT06631365?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2023-10-02. Estimated completion is 2025-04-01.

What conditions does trial NCT06631365 study?

This clinical trial studies the following conditions: HIV-1-infection.

What interventions are being tested in trial NCT06631365?

The interventions under investigation include: PrEPsmart mobile app (DEVICE), Truvada (DRUG).

Who is sponsoring clinical trial NCT06631365?

This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06631365 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV-1-infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV-1-infection

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.